ISRCTN ISRCTN88364607
DOI https://doi.org/10.1186/ISRCTN88364607
Secondary identifying numbers 2
Submission date
28/06/2024
Registration date
12/07/2024
Last edited
09/07/2024
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Current practice in groin hernia surgery for children in Uganda includes widely implemented task sharing as the surgeries are carried out by paediatric surgeons, general surgeons and medical doctors without formal surgical training after medical school and internship. The safety and effectiveness of this practice is not known. The study aims to assess the safety and effectiveness of task sharing in paediatric groin hernia surgery in Uganda.

Who can participate?
Children aged 1-12 years old, with reducible, primary, groin hernia and who are otherwise healthy (ASA 1-2) and where parents and child are willing to give informed consent and assent (children aged 8 years old and above).

What does the study involve?
The study involves a surgical procedure (inguinal hernia repair) performed by a consultant surgeon (non-paediatric surgeon) or a medical doctor (non-surgeon). It also involves interviews and physical examination before the surgery, at discharge from the hospital, after two weeks and after one year. Safety is the primary outcome and is defined as the occurrence of any postoperative complication at 2 weeks postoperatively. Secondary outcomes include hernia recurrence, patient satisfaction, chronic pain and quality of life one year postoperatively.

What are the possible benefits and risks of participating?
The main benefit of participating in the study is that the study participants will receive a groin hernia at no cost and will be followed up to detect any complications or recurrence. The study team will manage all unwanted outcomes after the surgery. Surgery is associated with certain risks but these risks are not elevated as a result of the study.

Where is the study run from?
The study is run from Uganda in three different hospitals - Soroti and Mubende Regional Referral Hospitals and Hope and Healing Centre outside Iganga town.

When is the study starting and how long is it expected to run for?
January 2020 to December 2030

Who is funding the study?
1. The Swedish Research Council
2. The Swedish Society of Medicine

Who is the main contact?
Dr Jenny Löfgren, jenny.lofgren@ki.se

Contact information

Dr Jenny Löfgren
Public, Scientific, Principal Investigator

Department of Molecular Medicine and Surgery
Karolinska University Hospital
L1:00
Stockholm
19176
Sweden

ORCiD logoORCID ID 0000-0001-5884-0369
Phone +46 (0)8 524 80000
Email jenny.lofgren@ki.se

Study information

Study designNon-inferiority randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment, Safety
Scientific titleOutcomes of paediatric inguinal hernia surgery performed by surgeons versus medical officers - a randomized controlled trial
Study hypothesisMedical doctors who are not surgeons can perform paediatric inguinal hernia surgery with non-inferior results compared to surgeons.
Ethics approval(s)

Approved 26/06/2024, Uganda Christian University Research and Ethics Committee (Plot 67-173, Bishop Tucker Road, Mukono, PO BOX 4, Uganda; +256 (0)312 350 800/880; info@ucu.ac.ug), ref: UCUREC-2024-829

ConditionInguinal hernia
InterventionInguinal hernia surgery will be carried out. The control arm will be operated on by specialist surgeons. The intervention arm will be operated on by medical doctors who are not surgeons but who have learnt this procedure on the job and who carry out hernia surgery in children as part of their work duties.

The randomization sequence will be generated online using blocks of 4, 6, and 8. The study number and randomization arm will be written on identical pieces of paper and sealed in opaque envelopes. At the beginning of each operation day, the operating list will be determined. Allocation to the control (surgeon) or intervention (MS) arm will be performed by a team member who will open the envelope when the next patient on the list is taken to the operating room. This person will not be involved in the operations or the generation of the operation list.
Intervention typeProcedure/Surgery
Primary outcome measureOccurrence of any postoperative complication assessed through patient/caregiver interview and physical examination at 2 weeks follow up
Secondary outcome measures1. Patient satisfaction, level of pain (according to the Inguinal Pain Questionnaire score from 1-7), and quality of life according to EQ5D, all assessed through patient/caregiver interviews + physical examination by a medical doctor 2 weeks postoperatively
2. Recurrence, chronic pain according to IPQ (same as above), patient satisfaction ("Are you satisfied with the result of the operation"?) and quality of life according to EQ5D assessed through patient /caregiver interview + physical examination by a medical doctor 1 year postoperatively
3. Costs and cost-effectiveness from the provider's perspective expressed as cost in USD per DALY averted at one timepoint
Overall study start date01/01/2020
Overall study end date31/12/2030

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit1 Year
Upper age limit12 Years
SexBoth
Target number of participants341
Participant inclusion criteria1. Child aged 1-12 years old
2. Primary reducible inguinal hernia
3. Otherwise healthy (ASA 1 and 2)
4. Willingness and ability of caregiver to give informed consent
5. Willingness and ability of child (8 years and above) to give informed assent
Participant exclusion criteria1. Previous surgery for inguinal hernia on the same side (i.e., recurrent hernia)
2. Comorbidity resulting in ASA classification 3 or higher
3. Irreducible/incarcerated hernia requiring emergency intervention
4. Caregiver/child not willing to participate
Recruitment start date16/07/2024
Recruitment end date31/12/2025

Locations

Countries of recruitment

  • Uganda

Study participating centres

Soroti Regoinal Referral Hospital
Plot 1-7 Gweri Road
3-7 Moroto Road
Soroti
PO Box 289
Uganda
Mubende Regional Referral Hospital
Plot 6 Kakumiro Road
Mubende
PO BOX 4
Uganda
Hope and Healing Center
Kiwanyi 1, Nawandala Subcounty
Iganga
PO Box 191
Uganda

Sponsor information

Karolinska Institutet
University/education

Department of Molecular Medicine and Surgery
Karolinska University Hospital
L1:00
Stockholm
17176
Sweden

Phone +46 (0)8-524 80000
Email anders.franco-cereceda@ki.se
Website https://ki.se
ROR logo "ROR" https://ror.org/056d84691

Funders

Funder type

Government

Vetenskapsrådet
Government organisation / National government
Alternative name(s)
Swedish Research Council, VR
Location
Sweden
Svenska Läkaresällskapet
Private sector organisation / Other non-profit organizations
Alternative name(s)
Swedish Society of Medicine, Swedish Medical Society, SLS
Location
Sweden

Results and Publications

Intention to publish date01/06/2026
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planThe researchers expect to publish several papers based on this research study. The first manuscript should be ready for submission to a medical journal towards the end of 2025.
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available due to patient confidentiality. There is no plan to share patient-level data openly and there is no ethical approval to do so. If anyone desires to assess the data, they may do so after first obtaining ethical approval from the relevant bodies in Uganda. They can contact Dr Jenny Löfgren, jenny.lofgren@ki.se, with their interest who will guide them on who to contact at the ethics board that has approved the study in Uganda.

Editorial Notes

01/07/2024: Study's existence confirmed by Uganda Christian University Research and Ethics Committee.